China Shineway Pharmaceutical Group Ltd (C1S) Stock Price & News

C1S:FRA

China Shineway Pharmaceutical Group Ltd

€0.90

-3.72%

(-0.035) 1D

Jun 5, 10:00:00 PM GMT+2 · EUR

All symbols

YTD

MAX

	Symbol	Price	Change	% Change

Generating top insights for C1S...

Open

€0.91

High

€0.91

Low

€0.90

Mkt. cap

7.00B

Avg. vol.

103.00

Volume

0.00

52-wk high

€1.10

52-wk low

€0.80

No. of employees

Open

€0.91

High

€0.91

Low

€0.90

Mkt. cap

7.00B

Avg. vol.

103.00

Volume

0.00

52-wk high

€1.10

52-wk low

€0.80

No. of employees

News stories

From sources across the web

MSN

6 minutes ago

SpaceX, Anthropic, and OpenAI won't be added to the S&P 500 in 2026. Here's what investors can do about it.

CNBC

1 day ago

Marvell Technology and Flex to join S&P 500 index, replacing Pool and Campbell's

MarketWatch

1 day ago

S&P 500 sees $1.8 trillion wipeout, Nasdaq tallies biggest point drop on record: What investors need to know about Friday’s selloff

Ars Technica

1 day ago

S&P 500 rejects SpaceX, also blocking entry for OpenAI and Anthropic

About China Shineway Pharmaceutical Group Ltd

CEO-

Employees2.82K

Founded2002

Headquarters-

SectorPharmaceutical industry

Websiteshineway.com.hk

All values in CNY	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Revenue	826.35M	826.35M	741.36M	741.36M
Cost of goods sold	229.55M	229.55M	205.06M	205.06M
Cost of revenue	229.55M	229.55M	205.06M	205.06M
Research and development expenses	25.19M	25.19M	26.36M	26.36M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	387.14M	387.14M	335.51M	335.51M
Operating expense	411.42M	411.42M	380.65M	380.65M
Total operating expenses	640.96M	640.96M	585.71M	585.71M
Operating income	185.39M	185.39M	155.65M	155.65M
Other non operating income	75.51M	75.51M	6.28M	6.28M
EBT including unusual items	387.34M	387.34M	247.29M	247.29M
EBT excluding unusual items	383.53M	383.53M	248.69M	248.69M
Income tax expense	80.01M	80.01M	79.65M	79.65M
Effective tax rate	20.66%	20.66%	32.21%	32.21%
Other operating expenses	-	-	-	-
Net income	307.33M	307.33M	167.64M	167.64M
Net profit margin	37.19%	37.19%	22.61%	22.61%
Earnings per share	-	-	-	-
Interest and investment income	109.14M	109.14M	87.60M	87.60M
Interest expense	-2.93M	-2.93M	-	-
Net interest expenses	106.21M	106.21M	87.60M	87.60M
Depreciation and amortization charges	-	-	-	-
EBITDA	222.36M	222.36M	177.54M	170.01M
Gain or loss from assets sale	-	-	-2.42M	-2.42M

AI content may include mistakes. Learn more

HelpSend feedbackPrivacy Terms Disclaimer

Finance

Research